Medicenna Therapeutics Operating Expenses Growth & History (MDNAF)
Medicenna Therapeutics's operating expenses was $22.4M for fiscal 2026.
View full Medicenna Therapeutics company overviewMedicenna Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $22.4M | $2.0M | +9.85% |
| 2025 | 2025-03-31 | $20.4M | $1.7M | +9.27% |
| 2024 | 2024-03-31 | $18.7M | $2.4M | +14.54% |
| 2023 | 2023-03-31 | $16.3M | −$6.2M | −27.46% |
| 2022 | 2022-03-31 | $22.5M | $5.1M | +29.19% |
| 2021 | 2021-03-31 | $17.4M | $9.2M | +110.98% |
| 2020 | 2020-03-31 | $8.2M | — | — |
Medicenna Therapeutics quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $5.5M | −$58,000 | −1.05% |
| Q4 2026 | 2026-03-31 | $5.8M | $103,000 | +1.80% |
| Q3 2026 | 2025-12-31 | $5.6M | — | — |
| Q2 2026 | 2025-09-30 | $5.5M | — | — |
| Q1 2026 | 2025-06-30 | $5.5M | — | — |
| Q4 2025 | 2025-03-31 | $5.7M | — | — |
Medicenna Therapeutics operating expenses trends
Over the last five fiscal years, Medicenna Therapeutics's operating expenses increased from $17.4M to $22.4M, a change of $5.0M. The latest reported quarter, Q1 2027, shows $5.5M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicenna Therapeutics source filings ↗